An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.

about

An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.

Item

http://www.wikidata.org/entity/Q40184254

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

An AAVP-based solid-phase tran ...... or translational applications.

@en

type

Item

label

An AAVP-based solid-phase tran ...... or translational applications.

@en

prefLabel

An AAVP-based solid-phase tran ...... or translational applications.

@en

P1476

An AAVP-based solid-phase tran ...... for translational applications

@en

P2093

G R Souza

http://www.w3.org/2001/XMLSchema#string

R L Sidman

http://www.w3.org/2001/XMLSchema#string

T L Smith

http://www.w3.org/2001/XMLSchema#string

W Arap

http://www.w3.org/2001/XMLSchema#string

P2860

Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature

Bottom-up assembly of hydrogels from bacteriophage and Au nanoparticles: the effect of cis- and trans-acting factors.

Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.

Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents

Three-dimensional tissue culture based on magnetic cell levitation.

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.

A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.

Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.

Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.

P2888

cgt.2017.19

P304

358-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2017.19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

R Pasqualini

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085596987

http://www.w3.org/2001/XMLSchema#string

P698

28548103

http://www.w3.org/2001/XMLSchema#string

P932

5605672

http://www.w3.org/2001/XMLSchema#string